|
DE102004031656A1
(de)
*
|
2004-06-30 |
2006-01-19 |
Merck Patent Gmbh |
Tetrahydrochinoline
|
|
MX2010009738A
(es)
|
2008-03-03 |
2010-09-30 |
Irm Llc |
Compuestos y composiciones como moduladores de la actividad de tlr.
|
|
TWI547522B
(zh)
|
2009-07-07 |
2016-09-01 |
愛爾康研究有限公司 |
環氧乙烷環氧丁烷嵌段共聚物組成物
|
|
US20110065698A1
(en)
*
|
2009-08-26 |
2011-03-17 |
Cylene Pharmaceuticals, Inc. |
Novel protein kinase modulators
|
|
JP2013053070A
(ja)
*
|
2009-11-06 |
2013-03-21 |
Takeda Chem Ind Ltd |
ジヒドロピロロキノリン誘導体
|
|
TW201200518A
(en)
|
2010-03-10 |
2012-01-01 |
Kalypsys Inc |
Heterocyclic inhibitors of histamine receptors for the treatment of disease
|
|
DE102010025786A1
(de)
*
|
2010-07-01 |
2012-01-05 |
Merck Patent Gmbh |
Pyrazolochinoline
|
|
TW201206936A
(en)
|
2010-07-19 |
2012-02-16 |
Alcon Res Ltd |
Methods and compositions for the treatment of allergy
|
|
US9540379B2
(en)
|
2011-01-31 |
2017-01-10 |
Boehringer Ingelheim International Gmbh |
(1,2,4)triazolo[4,3-A]quinoxaline derivatives as inhibitors of phosphodiesterases
|
|
EP2699572B1
(en)
*
|
2011-04-21 |
2016-08-10 |
Origenis GmbH |
Heterocyclic compounds as kinase inhibitors
|
|
WO2013039785A2
(en)
|
2011-09-12 |
2013-03-21 |
Kalypsys, Inc. |
Heterocyclic inhibitors of histamine receptors for the treatment of disease
|
|
RS57854B1
(sr)
|
2011-09-30 |
2018-12-31 |
C&C Res Lab |
Novi heterociklični derivati i njihove upotrebe
|
|
IN2014KN00948A
(enExample)
*
|
2011-10-04 |
2015-08-21 |
Janus Biotherapeutics Inc |
|
|
US20140045856A1
(en)
|
2012-07-31 |
2014-02-13 |
Boehringer Ingelheim International Gmbh |
4-Methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalenes
|
|
WO2014060113A1
(en)
|
2012-10-19 |
2014-04-24 |
Origenis Gmbh |
Novel kinase inhibitors
|
|
US9255105B2
(en)
*
|
2012-12-06 |
2016-02-09 |
Enaltec Labs Private Limited |
Process of preparing alcaftadine
|
|
BR122021012629B1
(pt)
|
2013-02-01 |
2022-06-07 |
Wellstat Therapeutics Corporation |
Compostos de amina, composição compreendendo os referidos compostos e usos dos mesmos
|
|
AU2014236606A1
(en)
*
|
2013-03-15 |
2015-09-24 |
Epigenetix, Inc. |
Oxazolo(5,4-c)quinolin-2-one compounds as bromodomain inhibitors
|
|
AU2013394970B2
(en)
*
|
2013-07-25 |
2017-11-23 |
Centre National De La Recherche Scientifique |
Pyrroloquinoline derivatives as 5-HT6 antagonists, preparation method and use thereof
|
|
US10688082B2
(en)
|
2015-06-11 |
2020-06-23 |
Merck Sharp & Dohme Corp. |
Aminopyrazine compounds with A2A antagonist properties
|
|
KR102070265B1
(ko)
*
|
2017-01-26 |
2020-01-28 |
한국화학연구원 |
신규한 [1,2,4]트리아졸로[4,3-a]퀴녹살린 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 BET 단백질 관련 질환의 예방 또는 치료용 약학적 조성물
|
|
WO2019177971A1
(en)
*
|
2018-03-12 |
2019-09-19 |
Mavupharma, Inc. |
Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1) inhibitors and uses thereof
|
|
WO2019200500A1
(zh)
|
2018-04-15 |
2019-10-24 |
苏州大学张家港工业技术研究院 |
1,2,4-三氮唑及其制备方法
|
|
WO2019206242A1
(zh)
*
|
2018-04-27 |
2019-10-31 |
北京鼎材科技有限公司 |
有机电致发光材料及器件
|
|
TW202021969A
(zh)
*
|
2018-05-31 |
2020-06-16 |
南韓商Ｃ＆Ｃ新藥研究所 |
雜環衍生物及其用途
|
|
CN109705141B
(zh)
*
|
2019-02-20 |
2020-05-29 |
苏州大学 |
一种恶唑并喹啉类化合物及其制备方法与应用
|
|
WO2021098734A1
(zh)
*
|
2019-11-19 |
2021-05-27 |
南京明德新药研发有限公司 |
作为atm抑制剂的有取代的喹啉吡咯酮类合物及其应用
|
|
WO2021150613A1
(en)
|
2020-01-20 |
2021-07-29 |
Incyte Corporation |
Spiro compounds as inhibitors of kras
|
|
US11739102B2
(en)
|
2020-05-13 |
2023-08-29 |
Incyte Corporation |
Fused pyrimidine compounds as KRAS inhibitors
|
|
WO2022047093A1
(en)
|
2020-08-28 |
2022-03-03 |
Incyte Corporation |
Vinyl imidazole compounds as inhibitors of kras
|
|
US11767320B2
(en)
|
2020-10-02 |
2023-09-26 |
Incyte Corporation |
Bicyclic dione compounds as inhibitors of KRAS
|
|
US12077539B2
(en)
|
2021-03-22 |
2024-09-03 |
Incyte Corporation |
Imidazole and triazole KRAS inhibitors
|
|
EP4067357A1
(en)
*
|
2021-03-30 |
2022-10-05 |
JW Pharmaceutical Corporation |
Novel crystalline form of 1-(8-bromopyrido[2,3-e][1,2,4]triazolo[4,3-a]pyrazin-4-yl)-n-methylazetidin-3-amine hydrogen sulfate monohydrate
|
|
CA3224674A1
(en)
|
2021-07-07 |
2023-01-12 |
Pei Gan |
Tricyclic compounds as inhibitors of kras
|
|
EP4396187A1
(en)
|
2021-08-31 |
2024-07-10 |
Incyte Corporation |
Naphthyridine compounds as inhibitors of kras
|
|
WO2023049697A1
(en)
|
2021-09-21 |
2023-03-30 |
Incyte Corporation |
Hetero-tricyclic compounds as inhibitors of kras
|
|
WO2023056421A1
(en)
|
2021-10-01 |
2023-04-06 |
Incyte Corporation |
Pyrazoloquinoline kras inhibitors
|
|
CR20240197A
(es)
|
2021-10-14 |
2024-08-07 |
Incyte Corp |
Compuestos de quinolina como inhibidores de kras
|
|
CN116969943A
(zh)
*
|
2022-04-28 |
2023-10-31 |
轩竹生物科技股份有限公司 |
三并环类二酰甘油激酶抑制剂及其用途
|
|
US20250382296A1
(en)
*
|
2022-08-03 |
2025-12-18 |
Abbisko Therapeutics Co., Ltd. |
Nitrogen-containing fused three ring prmt5 inhibitor, and preparation method therefor and pharmaceutical use thereof
|
|
JP2025533677A
(ja)
|
2022-09-26 |
2025-10-07 |
上海湃隆生物科技有限公司 |
新型ｐｒｍｔ５阻害剤およびその使用
|
|
EP4594520A2
(en)
|
2022-09-30 |
2025-08-06 |
Sixfold Bioscience Ltd. |
Compositions containing oligonucleotides with theranostic applications
|
|
CN116332789A
(zh)
*
|
2023-03-10 |
2023-06-27 |
上海康鹏科技股份有限公司 |
一种4-氨基-2-氟苯甲酰胺的制备方法
|